Sign In

Login

Password

Forgot Password ? Sign Up

CLEC12A (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "CLEC12A" in Czech language version.

refsWebsite
Global rank Czech rank
8doi.org
2nd place
4th place
8worldcat.org
5th place
3rd place
1nih.gov
4th place
8th place

doi.org

dx.doi.org

  • MARSHALL, Andrew S. J.; WILLMENT, Janet A.; PYŻ, Elwira. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. European Journal of Immunology. 2006-08, roč. 36, čís. 8, s. 2159–2169. Dostupné online [cit. 2019-08-28]. ISSN 0014-2980. DOI 10.1002/eji.200535628. 
  • MARSHALL, Andrew S. J.; WILLMENT, Janet A.; LIN, Hsi-Hsien. Identification and Characterization of a Novel Human Myeloid Inhibitory C-type Lectin-like Receptor (MICL) That Is Predominantly Expressed on Granulocytes and Monocytes. Journal of Biological Chemistry. 2004-01-22, roč. 279, čís. 15, s. 14792–14802. Dostupné online [cit. 2019-08-28]. ISSN 0021-9258. DOI 10.1074/jbc.m313127200. 
  • PYŻ, Elwira; HUYSAMEN, Cristal; MARSHALL, Andrew S. J. Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand. European Journal of Immunology. 2008-04, roč. 38, čís. 4, s. 1157–1163. Dostupné online [cit. 2019-08-28]. ISSN 0014-2980. DOI 10.1002/eji.200738057. 
  • YOSHIDA, Go J.; SAYA, Hideyuki. Therapeutic strategies targeting cancer stem cells. Cancer Science. 2015-10-21, roč. 107, čís. 1, s. 5–11. Dostupné online [cit. 2019-08-28]. ISSN 1347-9032. DOI 10.1111/cas.12817. 
  • ZHOU, Jianbiao. Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia. World Journal of Stem Cells. 2014, roč. 6, čís. 4, s. 473. Dostupné online [cit. 2019-08-28]. ISSN 1948-0210. DOI 10.4252/wjsc.v6.i4.473. 
  • LEONG, Steven R.; SUKUMARAN, Siddharth; HRISTOPOULOS, Maria. An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia. Blood. 2016-12-01, roč. 129, čís. 5, s. 609–618. Dostupné online [cit. 2019-08-28]. ISSN 0006-4971. DOI 10.1182/blood-2016-08-735365. 
  • LABORDA, Eduardo; MAZAGOVA, Magdalena; SHAO, Sida. Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2017-10-27, roč. 18, čís. 11, s. 2259. Dostupné online [cit. 2019-08-28]. ISSN 1422-0067. DOI 10.3390/ijms18112259. 
  • TASHIRO, Haruko; SAUER, Tim; SHUM, Thomas. Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Molecular Therapy. 2017-09, roč. 25, čís. 9, s. 2202–2213. Dostupné online [cit. 2019-08-28]. ISSN 1525-0016. DOI 10.1016/j.ymthe.2017.05.024. 

nih.gov

ncbi.nlm.nih.gov

  • CLEC12A C-type lectin domain family 12 member A [Homo sapiens (human)] - Gene - NCBI. www.ncbi.nlm.nih.gov [online]. [cit. 2019-08-28]. Dostupné online. 

worldcat.org

  • MARSHALL, Andrew S. J.; WILLMENT, Janet A.; PYŻ, Elwira. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. European Journal of Immunology. 2006-08, roč. 36, čís. 8, s. 2159–2169. Dostupné online [cit. 2019-08-28]. ISSN 0014-2980. DOI 10.1002/eji.200535628. 
  • MARSHALL, Andrew S. J.; WILLMENT, Janet A.; LIN, Hsi-Hsien. Identification and Characterization of a Novel Human Myeloid Inhibitory C-type Lectin-like Receptor (MICL) That Is Predominantly Expressed on Granulocytes and Monocytes. Journal of Biological Chemistry. 2004-01-22, roč. 279, čís. 15, s. 14792–14802. Dostupné online [cit. 2019-08-28]. ISSN 0021-9258. DOI 10.1074/jbc.m313127200. 
  • PYŻ, Elwira; HUYSAMEN, Cristal; MARSHALL, Andrew S. J. Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand. European Journal of Immunology. 2008-04, roč. 38, čís. 4, s. 1157–1163. Dostupné online [cit. 2019-08-28]. ISSN 0014-2980. DOI 10.1002/eji.200738057. 
  • YOSHIDA, Go J.; SAYA, Hideyuki. Therapeutic strategies targeting cancer stem cells. Cancer Science. 2015-10-21, roč. 107, čís. 1, s. 5–11. Dostupné online [cit. 2019-08-28]. ISSN 1347-9032. DOI 10.1111/cas.12817. 
  • ZHOU, Jianbiao. Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia. World Journal of Stem Cells. 2014, roč. 6, čís. 4, s. 473. Dostupné online [cit. 2019-08-28]. ISSN 1948-0210. DOI 10.4252/wjsc.v6.i4.473. 
  • LEONG, Steven R.; SUKUMARAN, Siddharth; HRISTOPOULOS, Maria. An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia. Blood. 2016-12-01, roč. 129, čís. 5, s. 609–618. Dostupné online [cit. 2019-08-28]. ISSN 0006-4971. DOI 10.1182/blood-2016-08-735365. 
  • LABORDA, Eduardo; MAZAGOVA, Magdalena; SHAO, Sida. Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2017-10-27, roč. 18, čís. 11, s. 2259. Dostupné online [cit. 2019-08-28]. ISSN 1422-0067. DOI 10.3390/ijms18112259. 
  • TASHIRO, Haruko; SAUER, Tim; SHUM, Thomas. Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Molecular Therapy. 2017-09, roč. 25, čís. 9, s. 2202–2213. Dostupné online [cit. 2019-08-28]. ISSN 1525-0016. DOI 10.1016/j.ymthe.2017.05.024.